HomeSLXN • NASDAQ
add
Silexion Therapeutics Corp
Previous close
$0.32
Day range
$0.28 - $0.34
Year range
$0.21 - $4.65
Market cap
4.25M USD
Avg Volume
8.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.25M | 54.70% |
Net income | -1.37M | -77.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.24M | -56.62% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.78M | — |
Total assets | 3.58M | — |
Total liabilities | 1.98M | — |
Total equity | 1.61M | — |
Shares outstanding | 250.49K | — |
Price to book | -0.00 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -1.37M | -77.39% |
Cash from operations | -1.75M | -92.32% |
Cash from investing | -6.00K | -101.18% |
Cash from financing | — | — |
Net change in cash | -1.81M | -371.17% |
Free cash flow | — | — |
About
Founded
2008
Website
